Roopa Sethi, MBBS, MD

Professional Background

Division Director, Division of Addiction Psychiatry – Kansas University Medical Center, Kansas – January 2024 – Present

Fellowship Training Director, Addiction Psychiatry Fellowship Program – Kansas University Medical Center, Kansas – July 2019 – Present

Medical Director, Opioid Treatment Program – Kansas City Metro Methadone Program, University of Kansas Health System – July 2020 – Present

Associate Professor of Psychiatry, Department of Psychiatry and Behavioral Sciences – Kansas University Medical Center, Kansas – July 2023 – Present

Director of Addiction Medicine – Southwest Network, Phoenix, AZ – Aug 27, 2013 – July 2016

• MBBS, MBBS, Kasturba Med. Col., Karnataka, India
• Other, Psychiatry , Carilion Clinic- Virginia Tech Carilion School Of Medicine , Roanoke , VA
• Clinical Fellowship, Addiction Psychiatry, Yale School Of Medicine , New Haven , CT
• Residency, Psychiatry , Carilion Clinic- Virginia Tech Carilion School Of Medicine , Roanoke , Virginia

• American Academy of Addiction Psychiatry , Director of Education committee for small / rural programs , Director, 2025 - Present
• American Academy of Addiction Psychiatry , Member, 2013 - Present
• American Psychiatric Association, APA, Member, 2013 - Present

---

• Sethi, R, Thapa, N, Saxena, A, Chahil, R. 2013. "K2/Spice": have you updated your differentials? A case report.. The primary care companion for CNS disorders, 15 (2)
• Sethi, Roopa, Hoang, Nguyen, Ravishankar, Dheepthi., Arakonam, McCracken, Megan, Manzardo, Ann., M.. 2020. Kratom (Mitragyna speciosa). The Primary Care Companion For CNS Disorders, 22 (1). https://doi.org/10.4088/pcc.19nr02507
• Sethi, R, Vasudeva, S. 2012. Doxazosin for the treatment of nightmares: does it really work? A case report.. The primary care companion for CNS disorders, 14 (5)
• HARTMANN, GRACE, SETHI , ROOPA . 2023. Hartmann, G. E., & Sethi, R. (2023). The Role of Non-Pharmaceutical Fentanyl–Contaminated Counterfeit Oxycodone in Increasing Opioid Overdoses: A Commentary Review. The Primary Care Companion for CNS Disorders, 25(6), 49836.. THE PRIMARY CARE COMPANION OF CNS DISORDERS
• Velagapudi, Vivek, Sethi, Roopa. 2023. Illicit Non-Pharmaceutical Fentanyl and its Analogs: A Short Review of Literature. Kansas Journal of Medicine, 16 (1), 25-27. https://doi.org/10.17161/kjm.vol16.18555
• konakanchi, Jaya , Sethi , Roopa . 2023. Konakanchi, J. S., & Sethi, R. (2023). The Growing Epidemic of Opioid Use Disorder in the Elderly and Its Treatment: A Review of the Literature. The Primary Care Companion for CNS Disorders, 25(1), 44998.
• Caitilin , Leconte , Sethi , Roopa . 2023. Leconte, C. E., & Sethi, R. (2023). The appearance of xylazine in the United States as a fentanyl adulterant. The Primary Care Companion for CNS Disorders, 25(6), 49730.. The Primary Care Companion for CNS Disorders,
• Sethi, Roopa, Ravishankar, Dheepthi., Arakonam, Nagireddy, Radha. 2021. Phenibut Dependence and Withdrawal. The Primary Care Companion For CNS Disorders, 23 (1). https://doi.org/10.4088/pcc.19l02457
• Konakanchi, Jaya., Sri, Sethi, Roopa. 2023. The Growing Epidemic of Opioid Use Disorder in the Elderly and Its Treatment. The Primary Care Companion For CNS Disorders, 25 (1). https://doi.org/10.4088/pcc.21r03223
• Noonan, Grace, Sethi, Roopa. 2023. Xylazine Use in Pregnancy: The Effects of the Fentanyl Adulterant Xylazine on Pregnant Patients and the Developing Fetus. Kansas Journal of Medicine, 16 (3), 277-279. https://doi.org/10.17161/kjm.vol16.20624